| Literature DB >> 23376340 |
Florian Roeber1, Aaron R Jex, Robin B Gasser.
Abstract
Parasitic nematodes (roundworms) of livestock have major economic impact globally. In spite of the diseases caused by these nematodes and some advances in the design of new therapeutic agents (anthelmintics) and attempts to develop vaccines against some of them, there has been limited progress in the establishment of practical diagnostic techniques. The specific and sensitive diagnosis of gastrointestinal nematode infections of livestock underpins effective disease control, which is highly relevant now that anthelmintic resistance (AR) is a major problem. Traditional diagnostic techniques have major constraints, in terms of sensitivity and specificity. The purpose of this article is to provide a brief background on gastrointestinal nematodes (Strongylida) of livestock and their control; to summarize conventional methods used for the diagnosis and discuss their constraints; to review key molecular-diagnostic methods and recent progress in the development of advanced amplification-based and sequencing technologies, and their implications for epidemiological investigations and the control of parasitic diseases.Entities:
Keywords: Biotechnology; Livestock; Parasites; Specific diagnosis
Mesh:
Year: 2013 PMID: 23376340 PMCID: PMC7126997 DOI: 10.1016/j.biotechadv.2013.01.008
Source DB: PubMed Journal: Biotechnol Adv ISSN: 0734-9750 Impact factor: 14.227
Fig. 1Generalized life cycle representing key gastrointestinal strongylid nematodes of small ruminants (adapted from Demeler, 2005). First-, second- and third-stage larvae (L1, L2 and L3, respectively) are ‘free-living’ in the environment. The fourth larval (L4) and adult stages (dioecious) are ‘parasitic’ in the gastrointestinal tract of the host. Disease in the host animal is caused by the adult and/or L4 stages, and depends on the species of nematode; intensity of infection; species, age and immunological/health status of the host; host response against the parasite; stress and other environmental and management factors (Kassai, 1999, Taylor et al., 2007).
The key morphological characteristics, pre-patent periods and locations in the host of the most important genera and species of gastrointestinal nematodes infecting sheep in Australasia (based on Anderson, 2000, Besier and Love, 2003, Gibbons, 2010, Levine, 1968, Taylor, 2007).
| Family | Species | Morphometrics/morphology | Prepatent period | Location in the host | |
|---|---|---|---|---|---|
| Length (mm) | Features | ||||
| Trichostrongylidae | ♂ 10-20 | Red pseudocoelomic fluid and white, coiled uterus, giving a barber’s pole appearance. Presence of vulvar flap depends on strain. | 18-21 | Abomasum | |
| ♀ 18-30 | |||||
| ♂ 7-8 | Small head and buccal cavity. | 15-21 | Abomasum | ||
| ♀ 10-12 | In females a vulvar flap can be present. | ||||
| ♂ 2-6 | Dissimilar spicules of unequal length. | 15-23 | Abomasum or stomach | ||
| ♀ 3-8 | |||||
| ♂ 4-8 | Equal length spicules with triangular tip. | 15-23 | Anterior small intestine | ||
| ♀ 5-9 | |||||
| ♂ 4-7 | Equal length spicules with sharp tips. | 15-23 | Anterior small intestine | ||
| ♀ 5-8 | |||||
| ♂ 4-7 | Dissimilar spicules with foot-like appearance | 15-23 | Small intestine | ||
| ♀ 6-7 | |||||
| ♂ 4-5 | Transverse striation of cuticle in all species. | 14-15 | Small intestine | ||
| ♀ 5-6 | Watch-spring-like body posture and presence a small cephalic vesicle are characteristic. | ||||
| Molineidae | ♂ 10-19 | Small but distinct cephalic vesicle. | 18 | Small intestine | |
| ♀ 15-29 | Very long spicules ending in a spoon-shaped terminal piece. | ||||
| ♂ 10-15 | Small but distinct cephalic vesicle. | 18 | Small intestine | ||
| ♀ 15-20 | Long and slender spicules with a narrow lanceolate membrane. | ||||
| Ancylostomatidae | ♂ 12-17 | Anterior end is bend dorsally, | 40-70 | Small intestine | |
| ♀ 19-26 | Buccal capsule with is equipped with two cutting plates. | ||||
| Chabertiidae | ♂ 12-16 | Have two leaf crowns and a shallow buccal capsule. Position of cervical papillae used fro species differentiation. | 40‐45 | Large intestine | |
| ♀ 14-18 | |||||
| ♂ 11-16 | Cervical papillae are situated posterior to the oesophagus. | 40-45 | Large intestine | ||
| ♀ 13-24 | |||||
| ♂ 13-14 | Mouth is directed antero-ventrally. | 42-50 | Large intestine | ||
| ♀ 17-20 | Buccal capsule is subglobular without teeth. | ||||
Key validation parameters employed for the assessment of a diagnostic test (based on Conraths and Schares, 2006, Pfeiffer, 2010, Thrusfield, 2005).
| Term | Definition | Method of assessment |
|---|---|---|
| Sensitivity | The proportion of animals with the disease and are test-negative. | Assessment of these two parameters requires an independent, valid criterion termed a “gold standard” used to define the true disease status of an animal. |
| Specificity | The proportion of animals without the disease and are test-negative. | |
| Agreement | The agreement in results between two diagnostic tests, with one of the tests being a generally accepted diagnostic method. | Frequently assessed by Kappa test, which measures the proportion of agreement beyond that to be expected by chance. |
| Accuracy | Refers to the concordance between test results and the ‘true’ clinical state. | Depends on the number of ‘false positives’ and ‘false negatives’, in comparison with the true infection state as determined by the “gold standard”. |
| Reliability | The extent to which test results are consistent in repeat experiments. | This includes the assessment of repeatability, reproducibility, inter- and intra-assay variability. Repeatability assessment can be done by running the test two or more times on the same samples in the same laboratory under the same conditions. Additionally the intraassay variability (between replicates within the same run) and interassay variability (replicates between different runs) can be assessed. |
Stages of validation of a diagnostic test (adapted from Conraths and Schares, 2006).
| Stages of test validation |
|---|
| 1. Feasibility studies |
| 2. Assay development and standardization |
| - Optimization of reagents, protocols and equipment |
| - Preliminary estimate of repeatability |
| - Determination of analytical sensitivity and specificity |
| 3. Determination of assay performance characteristics |
| - Diagnostic sensitivity and specificity |
| - Repeatability and reproducibility |
| 4. Monitoring the validity of assay performance |
| 5. Maintenance and enhancement of validation criteria |